Pharmamarketeer
wet- en regelgeving

Abbott’s high sensitivity Troponin─I blood test receives US FDA approval to detect heart attacks faster and accurately

1 oktober 2019
Pharma Biz

Abbott, announced that its ARCHITECT STAT High Sensitivity Troponin─I blood test has received clearance from the US Food and Drug Administration (FDA). As one of the most researched troponin diagnostic

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)